Can Hepatitis C Virus (HCV) RNA be undetectable but have a viral load titre of 100,000 (one lac)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HCV RNA Cannot Be Both Undetectable and Have a Titre of 100,000 IU/mL

It is not possible for HCV RNA to be simultaneously undetectable and have a viral load of 100,000 (one lac) IU/mL. These are contradictory findings as "undetectable" means the virus cannot be detected by the assay, while a specific numerical value indicates a quantifiable amount of virus is present 1.

Understanding HCV RNA Testing and Terminology

HCV RNA testing involves several key concepts:

  1. Detection threshold: Modern sensitive assays typically have lower limits of detection around 10-15 IU/mL 1
  2. Quantification threshold: Most assays have a lower limit of quantification (LLOQ) of 12-25 IU/mL 1, 2
  3. Testing terminology:
    • Undetectable: No HCV RNA detected (below the limit of detection)
    • Detectable but not quantifiable (DNQ): HCV RNA is detected but below the quantification threshold
    • Quantifiable: HCV RNA is present at levels that can be measured numerically

Why This Discrepancy Cannot Occur

There are several reasons why HCV RNA cannot be both undetectable and have a titre of 100,000 IU/mL:

  1. Definition conflict: By definition, "undetectable" means the viral load is below the detection limit of the assay (typically <15 IU/mL) 1

  2. Quantification range: A value of 100,000 IU/mL is well above the detection and quantification thresholds of all modern HCV RNA assays 1

  3. Testing standards: Guidelines recommend using sensitive real-time PCR tests with low detection thresholds (≤25 IU/mL) for monitoring HCV treatment 1

Possible Explanations for Such a Discrepancy

If faced with such contradictory results, consider:

  1. Laboratory error: Sample mix-up, reporting error, or transcription mistake

  2. Different assays: Different testing methods can yield varying results. Studies show discordance between assays like COBAS TaqMan and Abbott RealTime, though not to this extreme magnitude 3, 2

  3. Timing difference: Results might be from different time points during treatment

  4. Misinterpretation: Confusion between "detected below quantification limit" (DNQ) and "undetectable" 4

Clinical Implications

The distinction between undetectable and detectable HCV RNA is crucial for:

  1. Treatment decisions: Response-guided therapy depends on accurate viral load measurements 1

  2. Stopping rules: Treatment discontinuation decisions are based on specific HCV RNA thresholds 1

  3. SVR prediction: The likelihood of sustained virological response (SVR) correlates with the time to HCV RNA disappearance 1

Recommendations for Accurate HCV RNA Assessment

  1. Use standardized testing: Employ sensitive detection tests with lower detection thresholds <15 IU/mL, ideally real-time PCR tests 1

  2. Consistent methodology: Use the same assay throughout treatment monitoring 1

  3. Regular monitoring: Measure viral load at appropriate intervals as recommended by guidelines 1

  4. Proper interpretation: Understand the difference between undetectable, detectable but not quantifiable, and quantifiable results 1

If faced with contradictory results like this, repeat testing is warranted to resolve the discrepancy before making clinical decisions.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.